Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Rapid Micro Biosystems Q4 EPS $(0.26) Beats $(0.30) Estimate, Sales $6.34M Beat $6.15M Estimate

Author: Benzinga Newsdesk | March 01, 2024 07:35am
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.30) by 13.33 percent. This is a 33.33 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $6.34 million which beat the analyst consensus estimate of $6.15 million by 3.04 percent. This is a 44.88 percent increase over sales of $4.37 million the same period last year.

Posted In: RPID


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist